Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Immunic Inc’s stock clocked out at $0.89, up 2.08% from its previous closing price of $0.87. In other words, the price has increased by $2.08 from its previous closing price. On the day, 1.39 million shares were traded.
Ratios:
To gain a deeper understanding of IMUX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.74 and its Current Ratio is at 0.74.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 05 ’25 when Tardio Jason bought 12,512 shares for $0.79 per share. The transaction valued at 9,884 led to the insider holds 12,512 shares of the business.
Vitt Daniel bought 15,000 shares of IMUX for $11,550 on Jun 04 ’25. The CEO and Director now owns 29,000 shares after completing the transaction at $0.77 per share. On Jun 04 ’25, another insider, Neermann Joerg, who serves as the Director of the company, bought 70,000 shares for $0.77 each. As a result, the insider paid 53,900 and bolstered with 170,000 shares of the company.
Stock Price History:
Over the past 52 weeks, IMUX has reached a high of $2.11, while it has fallen to a 52-week low of $0.56. The 50-Day Moving Average of the stock is -8.17%, while the 200-Day Moving Average is calculated to be -24.27%.
Shares Statistics:
A total of 95.82M shares are outstanding, with a floating share count of 92.59M. Insiders hold about 3.37% of the company’s shares, while institutions hold 40.58% stake in the company.
